While the other literature may primarily focus on the genetics of retinoblastomas, the role of RB1 mutations, molecular mechanisms, or technical aspects of mutation detection, this review focuses on the practical application of genetic testing and its importance in the clinical management of retinoblastoma patients, thereby endowing clinicians with the necessary tools and knowledge to optimize patient care. This evidence concerns the gene RB1 and retinoblastoma.